Esketamine is different from ketamine as its S-enantiomer, delivered as a prescription nasal spray marketed as Spravato. Unlike traditional antidepressants that target serotonin, esketamine acts on glutamate receptors, which is why it can work faster for some patients with treatment-resistant depression.
Frequently asked